We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

148 hedge funds and large institutions have $552M invested in Aerie Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $627K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

5% less funds holding

Funds holding: 155 → 148 (-7)

23% less capital invested

Capital invested by funds: $712M → $552M (-$160M)

27% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 22

Holders
148
Holders Change
-7
Holders Change %
-4.52%
% of All Funds
2.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
50
Reduced
50
Closed
22
Calls
$1.26M
Puts
$627K
Net Calls
+$635K
Net Calls Change
+$1.36M

Top Buyers

Rank Fund Capital Flow
1
CWG
C WorldWide Group
Denmark
+$11M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$9.08M
3
Goldman Sachs
Goldman Sachs
New York
+$8.33M
4
Bank of America
Bank of America
North Carolina
+$5.55M
5
Ameriprise
Ameriprise
Minnesota
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$10.4M
2
FAM
Fred Alger Management
New York
-$9.68M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.12M
4
Handelsbanken Fonder
Handelsbanken Fonder
Sweden
-$6.5M
5
LCS
Levin Capital Strategies
New York
-$4.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
26
VOYA Investment Management
Georgia
$7.08M +$147K +12,040 +2%
N
27
Nuveen
North Carolina
$7.04M +$144K +11,794 +2%
CS
28
Candriam SCA
Luxembourg
$6.96M – – –
PA
29
Pinnacle Associates
New York
$6.17M -$160K -13,110 -2%
FCM
30
Frontier Capital Management
Massachusetts
$6.14M +$195K +16,023 +3%
DM
31
Deerfield Management
New York
$5.82M – – –
Northern Trust
32
Northern Trust
Illinois
$5.81M -$246K -20,170 -4%
First Manhattan
33
First Manhattan
New York
$5.63M -$1.52M -124,500 -21%
NAM
34
Nexpoint Asset Management
Texas
$5.21M – – –
GIP
35
Granite Investment Partners
California
$4.93M +$2.11M +173,418 +71%
Norges Bank
36
Norges Bank
Norway
$4.02M -$707K -58,031 -15%
Renaissance Technologies
37
Renaissance Technologies
New York
$3.76M +$403K +33,100 +12%
DCM
38
DAFNA Capital Management
California
$3.35M +$60.9K +5,000 +2%
Charles Schwab
39
Charles Schwab
California
$3.32M +$191K +15,706 +6%
Deutsche Bank
40
Deutsche Bank
Germany
$3.19M +$1.91M +156,897 +137%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$2.51M -$2.33M -191,302 -47%
AGA
42
Altrinsic Global Advisors
Connecticut
$2.47M +$731K +60,000 +40%
Alyeska Investment Group
43
Alyeska Investment Group
Illinois
$2.45M – – –
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$2.42M +$1.27M +104,282 +103%
Point72 Asset Management
45
Point72 Asset Management
Connecticut
$2.16M -$8.12M -666,992 -78%
Stifel Financial
46
Stifel Financial
Missouri
$1.86M +$712K +58,427 +59%
Allianz Asset Management
47
Allianz Asset Management
Germany
$1.79M +$133K +10,950 +8%
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
$1.77M +$1.84M +150,790 New
Barclays
49
Barclays
United Kingdom
$1.53M -$579K -47,523 -27%
CSS
50
Cubist Systematic Strategies
Connecticut
$1.48M -$217K -17,832 -12%
1
2
3 4 5

AERI Hedge Fund Activity: Q3 2020 in Review

148 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2020, worth a combined $552M — down 23% from $712M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of AERI and 16 opened new positions — a net loss of 6 holders — while 50 trimmed existing stakes and 50 added.

The largest buyer was C WorldWide Group, adding an estimated $11M. The largest seller was Citadel Advisors, cutting an estimated $10.4M.

  • 148 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2020, down from 155 in Q2 2020.
  • Funds reported $552M of Aerie Pharmaceuticals stock for Q3 2020, down 23% quarter-over-quarter.
  • 16 funds opened new Aerie Pharmaceuticals positions in Q3 2020 and 22 closed out, a net change of -6 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2020 was C WorldWide Group, an estimated $11M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2020 was Citadel Advisors, an estimated $10.4M sold.

Based on aggregated 13F filings for Q3 2020.